dc.contributor.author | Morgan, Christopher L.l. | |
dc.contributor.author | Emery, Paul | |
dc.contributor.author | Porter, Duncan | |
dc.contributor.author | Reynolds, Alan | |
dc.contributor.author | Young, Adam | |
dc.contributor.author | Boyd, Helen | |
dc.contributor.author | Poole, Chris D. | |
dc.contributor.author | Currie, Craig J. | |
dc.date.accessioned | 2014-04-09T09:30:24Z | |
dc.date.available | 2014-04-09T09:30:24Z | |
dc.date.issued | 2014-01 | |
dc.identifier.citation | Morgan , C L L , Emery , P , Porter , D , Reynolds , A , Young , A , Boyd , H , Poole , C D & Currie , C J 2014 , ' Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs : long-term safety and survival using prospective, observational data ' , Rheumatology , vol. 53 , no. 1 , pp. 186-94 . https://doi.org/10.1093/rheumatology/ket333 | |
dc.identifier.issn | 1462-0324 | |
dc.identifier.uri | http://hdl.handle.net/2299/13313 | |
dc.description.abstract | The objective of this study was to examine the long-term safety of etanercept (ETN) in comparison with conventional DMARDs in a large observational cohort of RA patients in the UK. | en |
dc.format.extent | 9 | |
dc.language.iso | eng | |
dc.relation.ispartof | Rheumatology | |
dc.subject | Antirheumatic Agents | |
dc.subject | Arthritis, Rheumatoid | |
dc.subject | Female | |
dc.subject | Follow-Up Studies | |
dc.subject | Forecasting | |
dc.subject | Great Britain | |
dc.subject | Humans | |
dc.subject | Immunoglobulin G | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Prospective Studies | |
dc.subject | Receptors, Tumor Necrosis Factor | |
dc.subject | Survival Rate | |
dc.subject | Treatment Outcome | |
dc.subject | Tumor Necrosis Factor-alpha | |
dc.title | Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs : long-term safety and survival using prospective, observational data | en |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.contributor.institution | Basic and Clinical Science Unit | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1093/rheumatology/ket333 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |